How is India Strengthening Health Ties with Fiji?
Click to start listening
Synopsis
India takes a significant step in its commitment to health partnerships by sending ARV drugs to Fiji. This initiative is part of a broader strategy to enhance healthcare services in the Global South. Discover how this collaboration aims to improve health outcomes and strengthen ties between the two nations.
Key Takeaways
- India's commitment to Global South health partnerships is evident through the provision of ARV drugs.
- The collaboration aims to enhance health services in Fiji.
- Discussion of a super specialty hospital in Suva highlights future healthcare investments.
- Jan Aushadhi Kendras will ensure affordable medicines for all.
- Telemedicine initiatives will improve health connectivity.
New Delhi, Nov 1 (NationPress) In a demonstration of its unwavering commitment to the health partnership with the Global South, India has dispatched a shipment of Anti-Retro Viral (ARV) drugs to Fiji on Saturday, aimed at enhancing the health services of the island nation.
The Ministry of External Affairs (MEA) took to X to announce, "A consignment of Anti-Retro Viral (ARV) drugs has been sent to Fiji to bolster its health initiatives. India is dedicated to supporting Fiji in its public health response and humanitarian requirements."
In August, during his visit to India, Fijian Prime Minister Sitiveni Rabuka engaged in extensive and future-oriented discussions with PM Narendra Modi, covering a wide range of bilateral issues and regional as well as global topics of common interest.
The leaders expressed their satisfaction with the evolution of their relationship and reaffirmed their commitment to establishing a comprehensive, inclusive, and forward-thinking partnership across various sectors such as defence, health, agriculture, agro-processing, trade, investment, small and medium enterprise development, cooperatives, culture, sports, education, and skill enhancement.
PM Modi also welcomed the signing of a Memorandum of Understanding regarding the Recognition of Indian Pharmacopoeia in May 2025, which aims to enhance collaboration in the pharmaceutical domain and ensure better access to quality, affordable healthcare products and services in Fiji.
He reiterated India’s support for setting up Jan Aushadhi Kendras (People’s Pharmacies) in Fiji to offer low-cost generic medicines.
"In our extensive discussions today, we made numerous significant decisions. We believe that only a healthy nation can thrive. Therefore, we resolved to establish a 100-bed super specialty hospital in Suva. Dialysis units and sea ambulances will also be provided. Moreover, Jan Aushadhi Kendras will be launched to ensure that affordable, high-quality medications reach every household. We want to ensure that no one is hindered in their pursuit of dreams, hence, a 'Jaipur Foot' camp will also be organized in Fiji," stated PM Modi.
Both leaders welcomed the convening of the 3rd Joint Working Group on Health between India and Fiji on August 13, during which cooperation under India’s flagship telemedicine initiative, e-Sanjeevani, was discussed to enhance remote healthcare services and improve digital health connectivity between the two nations.
Point of View
This initiative by India highlights its commitment to global health equity, particularly in the Global South. By providing essential ARV drugs to Fiji, India showcases its role as a responsible partner in addressing health challenges. Such collaborations are vital for enhancing healthcare accessibility and strengthening international ties, ensuring that nations can thrive together.
NationPress
02/11/2025
Frequently Asked Questions
What are ARV drugs?
ARV drugs are medications used to treat HIV/AIDS, helping to manage the virus and improve the quality of life for those affected.
Why is India sending ARV drugs to Fiji?
India is sending ARV drugs to support Fiji's health program and reaffirm its commitment to global health partnerships, particularly in the Global South.
What other health initiatives are being discussed?
In addition to ARV drugs, discussions include establishing a super specialty hospital in Suva and launching Jan Aushadhi Kendras for affordable medicines.
What is the significance of the MOU on the Indian Pharmacopoeia?
The MOU aims to enhance collaboration in the pharmaceutical sector, ensuring better access to quality healthcare products in Fiji.
How will telemedicine play a role in this partnership?
Telemedicine initiatives like e-Sanjeevani will facilitate remote healthcare services and improve health connectivity between India and Fiji.
